Reference no: EM132885711
Question - On December 30, 2020, the Oxford-AstraZenecaAstraZeneca Costs Amount vaccine was approved for use in the UK. On that date, the vaccine's manufacturer, , progressed through the additional development procedures necessary to gain approval in the USA. Throughout 2021, management incurred the following development costs in the process to obtain the approval of the US Food and Drug Administration (FDA):
Providing safety information for review to FDA $1,600,000
Designing vaccination containers in line with FDA's requirements $17,000,000
Cost of personnel responsible for administrating the vaccine in the USA $6,000,000
Cost to educate its sales force and perform market research in the USA $15,000,000
Based on your expertise in IAS 38:
Required -
1. Advise AstraZeneca on whether or not the development costs spent in 2021 meet the criteria for capitalization under IAS 38.
2. Record the journal entries at the end of 2021.